Clovis Oncology’s Rubraca® (Rucaparib) Granted FDA Priority Review For Advanced Prostate Cancer

[curious-mind1]

Approval should follow quickly, it seems: ir.clovisoncology.com/inves...

Art

[JLS1]

I'm not sure, but I think this may be the drug that our oncologist said is actually better/stronger vs. Lynparza. I had asked him if it might be worth trying since he felt going back to Lynparza might be an option (we stopped Lynparza after 1-1/2 years to use Xofigo). He said insurance might prevent that, since they already covered Lynparza and Rucaparib wasn't approved for prostate cancer yet. I'm hoping FDA approval may change that!